⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

January 10, 2000The Journal of Cell BiologyOpen Access

Filamin 2 (FLN2): A Muscle-specific Sarcoglycan Interacting Protein

View Full Paper

Ask AI

Bookmark

Share

Authors

TTTerri G. ThompsonLightPointe (United States)YCYiu-mo ChanGeisinger Medical Center AHAndrew A. HackHoward Hughes Medical Institute

Discussion

Loading...

Member takes

Implication

Novel sarcoglycan interactor expands DGC map; leaves open its role in muscular dystrophy pathogenesis.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Thompson et al. (2000) studied this question.

synapsesocial.com/papers/6a7cc3e580d29ce2cbfaba71 https://doi.org/10.1083/jcb.148.1.115

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

1Loss of the Sarcoglycan Complex and Sarcospan Leads to Muscular Dystrophy in -Sarcoglycan-Deficient Mice1999 · 162 citations
2Interactions between actin, myosin, and an actin-binding protein from rabbit alveolar macrophages. Alveolar macrophage myosin Mg-2+-adenosine triphosphatase requires a cofactor for activation by actin.1975 · 157 citations
3Progressive Muscular Dystrophy in α-Sarcoglycan–deficient Mice1998 · 356 citations